Dr. Courtney is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-645-4673Fax+1 214-645-2542
Summary
- Dr. Kevin Courtney is a medical oncologist in Dallas, TX with University of Texas Southwestern Medical Center and the UT Southwestern Harold C. Simmons Comprehensive Cancer Center. He received his MD and his PhD in Molecular Cancer Biology from Duke University School of Medicine. He specializes in genitourinary oncology.
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2005 - 2008
University of California (San Francisco)Residency, Internal Medicine, 2002 - 2005
Duke University School of MedicineClass of 2002
Certifications & Licensure
TX State Medical License 2012 - 2025
MA State Medical License 2005 - 2012
CA State Medical License 2004 - 2005
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Publications & Presentations
PubMed
- The role of the radiologist in the prostate cancer multidisciplinary conference.Daniel N Costa, Nghi Nguyen, Aurelie Garant, Xiaosong Meng, Kevin D Courtney
Abdominal Radiology. 2024-11-01 - The Use of Lurbinectedin for the Treatment of Small Cell and Neuroendocrine Carcinoma of the Prostate.Haley Meyer, Rajitha Sunkara, Emily Rothmann, Amar Shah, Irbaz Riaz
Clinical Genitourinary Cancer. 2024-10-01 - 13 citationsMitochondrial complex I promotes kidney cancer metastasis.Divya Bezwada, Luigi Perelli, Nicholas P Lesner, Ling Cai, Bailey Brooks
Nature. 2024-09-01
Journal Articles
- Blocking Monocytic Myeloid-Derived Suppressor Cell Function via Anti-DC-HIL/GPNMB Antibody Restores the in Vitro Integrity of T-cells from Cancer PatientsKevin Courtney, Yull Arriaga, Barbara Haley, John C Mansour, Ponciano D Cruz, David Harker, Farshid Araghizadeh, Clinical Cancer Research
Press Mentions
UTSW’s Simmons Cancer Center Awarded More Than $11.5 Million in CPRIT FundingSeptember 6th, 2024- Children’s Research Institute at UT Southwestern Scientists Discover Kidney Cancers Rely on Mitochondrial Metabolism to MetastasizeAugust 14th, 2024
Findings Establish PT2385 as a Highly Specific HIF-2 Inhibitor for Patients with Clear Cell RCCFebruary 27th, 2020- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
